dihydroxyphenylalanine has been researched along with Cholangiocarcinoma in 1 studies
Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.
Cholangiocarcinoma: A malignant tumor arising from the epithelium of the BILE DUCTS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, CW | 1 |
| Yeh, CN | 1 |
| Chung, YH | 1 |
| Chen, YR | 1 |
| Tien, SW | 1 |
| Chen, TW | 1 |
| Farn, SS | 1 |
| Huang, YC | 1 |
| Yu, CS | 1 |
1 other study available for dihydroxyphenylalanine and Cholangiocarcinoma
| Article | Year |
|---|---|
Synthesis and evaluation of
Topics: Animals; Celecoxib; Cholangiocarcinoma; Cyclooxygenase 2; Dihydroxyphenylalanine; Disease Models, An | 2018 |